|
WO2009055002A1
|
|
Combined inhibitors of cyclooxygenase and semicarbazide-sensitive amine oxidase (ssao) (vascular adhesion protein, vap-1)
|
|
EP2004166A2
|
|
Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
|
|
US2006229270A1
|
|
Methods of treating proteinuria by reducing double-stranded DNA antibodies
|
|
WO2006094201A2
|
|
Semicarbazide-sensitive amide oxidase inhibitors
|
|
EP2283833A2
|
|
Amines and amides for the treatment of diseases
|
|
CN1921841A
|
|
Amines and amides for the treatment of diseases
|
|
EP1663954A2
|
|
Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases
|
|
CN1863763A
|
|
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and vap-1 mediated adhesion useful for treatment of diseases
|
|
AU2003303524A8
|
|
Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
|
|
EP1387697A2
|
|
Methods of treating antibody-mediated pathologies using agents which inhibit cd21
|
|
US7115581B2
|
|
Chemically-defined non-polymeric valency platform molecules and conjugates thereof
|
|
CA2355348A1
|
|
Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function
|
|
CN1434726A
|
|
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
|
CN101422614A
|
|
Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof
|
|
AU5479600A
|
|
Valency platform molecules comprising aminooxy groups
|
|
CA2353462A1
|
|
Molecular scaffolds acting as templates comprising carbamate linkages
|
|
EP1135167A2
|
|
Methods and formulations for reducing circulating antibodies
|
|
US6458953B1
|
|
Valency platform molecules comprising carbamate linkages
|
|
US6399578B1
|
|
Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
|
|
US6858210B1
|
|
Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
|
